Tizanidine Tablet
Product Images NDC 68788-8802

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 68788-8802). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 01)

Chemical structure of Tizanidine hydrochloride, showing the molecular arrangement including a chlorinated benzene ring fused with a thiazole and an attached imidazoline ring.*

FDA Label Image

Figure-1 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 02)

A line graph showing plasma Tizanidine concentration (ng/mL) over time (hours) after dosing. The graph compares 4 mg Tizanidine tablets and capsules taken with and without food, illustrating concentration changes from 0 to 24 hours post-dose with four distinct lines representing each condition.*

FDA Label Image

Figure 3 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 03)

A line graph showing improvement in Ashworth Score over time (hours post-dose) for three groups: 16 mg tizanidine, 8 mg tizanidine, and placebo. The y-axis measures improvement in Ashworth Score, and the x-axis shows hours post-dose from 0 to 6. Data points include error bars indicating variability.*

FDA Label Image

Figure 4 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 04)

A line graph comparing improvements in Ashworth Score between tizanidine (mean dose 28.8 mg) and placebo groups at three study intervals: end of titration (week 3), end of maintenance (week 7), and endpoint (last observation carried forward). The vertical axis represents improvement in Ashworth Score, with data points and error bars indicating mean values and variability for each group over time.*

FDA Label Image

Logo (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 05)

FDA Label Image

Tizanidine Tablets Usp 4mg (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 07)

Label for Tizanidine Tablets USP 4 mg, a human prescription drug by Preferred Pharmaceuticals Inc. The label includes directions for use in English and Spanish on a yellow background, caution statements, and manufacturer details for Unichem Laboratories Ltd. It notes the tablet strength as 4 mg, tablet appearance as round and white, and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.